Gliding along the development path: Jumpcan Pharmaceutical is a national high-tech group in Taixing city. [Photo/WeChat account: txfabu]
Jumpcan Pharmaceutical – based in Taixing city, in East China's Jiangsu province – was recently ranked 11th in the list of 2023 Top 20 Competitiveness of Chinese Pharmaceutical Listed Companies.
Organized by the China Pharmaceutical Enterprise Association, the selection conducted comprehensive assessments of enterprises. It applied the metrics of entrepreneurship, capital, industry, resources and management, undertaking the selection over 15 consecutive sessions.
It was determined that Jumpcan has continued its layout of research and development for difficult generic drugs, high-end formulations and innovative drugs. Furthermore, it has promoted the secondary development of large varieties of traditional Chinese medicine and improved innovative drugs for TCM.
Goals are for the company to provide more diverse and high-quality products for Chinese patients. As a result, it will meet the varied medication needs of the public and strive to become a trusted and leading pharma group.